PETRI DISH PERSPECTIVES
Burma | Chicago
Scientist 🥼🧪🔬
Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎
Stream new episodes every THURSDAY!
https://linktr.ee/maneadkhin
#biotech #pharma #healthcare #podcast #petridishperspectives
PETRI DISH PERSPECTIVES
Latest Episodes
Episode 80: Dr. Meesha Dogan on Using AI and Epigenetics to Detect Heart Disease Early
After a two-generation family history of heart disease, Dr. Meesha Dogan set out to change how the disease is detected. As founder and CEO of Cardio Diagnostics, she built and commercialized what the company describes as the first epigenetics-b...
October 2026: Biotech & Pharma NEWS Roundup
Welcome to your essential overview of the global biotech and pharmaceutical landscape for October 2026!This month was defined by a wave of oncology approvals, a head-to-head data drop that reshuffled the GLP-1 race, and M&A activity ...
Episode 79: Endeavor Health
In this episode of Petri Dish Perspectives, we explore Endeavor Health, the Chicago-area hospital system most Illinoisans have driven past but couldn’t name. Born from Evanston Hospital in 1891, grown into NorthShore University HealthSystem, ex...
Episode 78: Dr. Kristin Gleitsman on Using AI to Make Better Drug Development Decisions
After years of building discovery engines inside diagnostics, Kristin Gleitsman has become one of the more skeptical voices in AI and biology. A Caltech chemistry PhD, Kristin built Veracyte’s Discovery Research function from the ground up and ...
Episode 77: Revolution Medicines
In this episode of Petri Dish Perspectives, we explore Revolution Medicines, the precision oncology company that spent over a decade trying to drug one of cancer’s most notorious targets: RAS. With mutations present in roughly 30% of all new ca...
